Navigation Links
ResMed Inc. Announces Record Financial Results For The Quarter Ended And Nine Months Ended March 31, 2013
Date:4/25/2013

SAN DIEGO, April 25, 2013 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced record revenue and income for the quarter ended March 31, 2013.  Revenue for the quarter ended March 31, 2013 was $383.6 million, a 10% increase (also a 10% increase on a constant currency basis) over the quarter ended March 31, 2012.  For the quarter ended March 31, 2013, net income was $84.9 million, an increase of 31% compared to the quarter ended March 31, 2012.  Diluted earnings per share for the quarter ended March 31, 2013 were $0.58, an increase of 32% compared to the quarter ended March 31, 2012. 

(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

SG&A expenses were $109.6 million for the quarter ended March 31, 2013, an increase of $7.7 million, or 8% (also an 8% increase on a constant currency basis) compared to the quarter ended March 31, 2012.  SG&A costs were 28.6% of revenue in the quarter ended March 31, 2013, compared to 29.2% for the quarter ended March 31, 2012.
 

R&D expenses were $31.2 million for the quarter ended March 31, 2013, an increase of $2.8 million, or 10% (an 11% increase on a constant currency basis) compared to the quarter ended March 31, 2012.  R&D expenses were 8.1% of revenue in the quarter ended March 31, 2013, consistent with 8.1% for the quarter ended March 31, 2012.

The company amortized acquired intangibles of $2.5 million ($1.9 million, net of tax) during the quarter ended March 31, 2013.  Stock-based compensation costs incurred during the quarter ended March 31, 2013 of $10.2 million ($7.2 million, net of tax) consisted of expenses associated with stock options, restricted stock units, and our employee stock purchase pl
'/>"/>

SOURCE ResMed Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment
2. ResMed Announces Conference Call And Webcast To Discuss Third Quarter 2013 Results
3. ResMed Takes Action to Enforce Patents
4. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
5. ResMed Inc. Announces Record Financial Results For The Quarter Ended And Six Months Ended December 31, 2012
6. ResMed Inc. Announces Exchange Rate For Upcoming Dividend Payment
7. ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2012
8. ResMed Inc. Announces Record Financial Results For The Quarter And Twelve Months Ended June 30, 2012
9. ResMed Announces Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year-End 2012 Results
10. ResMed Launches Narval™ CC Mandibular Repositioning Device in the US
11. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... May 29, 2015 Actinobac Biomed, NovoPedics, Inc. ... with investments from Foundation Venture Capital Group (FVCG), have ... 2015 as part of the Start-Up Stadium and Company ... James M. Golubieski . The ... will be held in Philadelphia ...
(Date:5/29/2015)... 29, 2015 Eli Lilly and Company (NYSE: ... Annual Global Healthcare Conference on Tuesday, June 9, 2015. ... Elanco Animal Health, will participate in a fireside chat ... A live audio webcast will be available on the ... http://investor.lilly.com/events.cfm . A replay of the fireside chat ...
(Date:5/29/2015)... and SPARTANBURG, South Carolina ... Guardian Research Network and Molecular Health have announced a ... molecular diagnostic decision support to the majority of cancer ... Research Network will collaborate with Molecular Health to harness ... to identify cohorts from hundreds of thousands of patients ...
Breaking Medicine Technology:Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 2Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 3Lilly to Participate in Goldman Sachs Global Healthcare Conference 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 4
... 19, 2011 Business Monitor International (BMI) has announced ... The healthcare and pharmaceutical analysis ... for drugs and healthcare expenditure, imports and exports, and ... patented drugs and generics market segments. The forecasts are ...
... BEND, Wis., May 19, 2011 Leading-edge Clinical ... Research, LLC proudly receives the 2011 IQ (Innovation ... School of Management and BizTimes Media, a magazine ... and strategic insights. The revolutionary Spaulding IQ(SM) electrocardiogram ...
Cached Medicine Technology:Business Monitor International Launches Report on China's Pharmaceutical and Healthcare Industry 2Spaulding Clinical Honored at BizTech Conference 2
(Date:5/29/2015)... 2015 Dot Hill can mark one more item ... Lake Prince Woods retirement community is the oldest woman ... Virginia. , “It was great fun!”, she exclaimed. “I’ve always ... me to so they thought this would be ok.” , “We ... vertical wind tunnel,” she described. “I don’t remember it being ...
(Date:5/29/2015)... CA (PRWEB) May 29, 2015 On May ... You Really be When You Get Botox ?” reported ... according to Google. Elle partnered with Google to determine these ... The most searched question in California, for example, is how ... the most common search query is what's the appropriate age ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Jan Wooden Howse ... in one thing above all else: God does no wrong. ... subject of her son’s passing is titled “God Does No ... is confronted with great personal tragedy. , “My story ... someone dear to you into something productive, something healing,” Howse ...
(Date:5/29/2015)... May 29, 2015 Johnson & ... a confidential Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) settlement ... due to his use of the antipsychotic medication. ... selected for the third bellwether trial to involve ... litigation underway in Pennsylvania’s Philadelphia Court of Common ...
(Date:5/29/2015)... California (PRWEB) May 29, 2015 A group ... and have joined the national effort to teach this “new ... in the U.S. have been “sickened” by the recent implementation ... love it or hate it, Common Core is now a ... of Columbia. Parents are now seeking ways to improve ...
Breaking Medicine News(10 mins):Health News:Indoor Skydiving Brings Thrills to Seniors 2Health News:Botox, Wrinkles and Double Chins: The Most-Asked Beauty Problems According to Google 2Health News:Turning grief from a child’s passing into virtue 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:Doctors Discover a Cure for the Common Core 2
... , , TEWKSBURY, Mass., ... is; on eggnog, cookies, candy and holiday buffet fare even though we ... the same with our four-legged, furry companions. The advent of the New ... for our pets, according to the experts at Wellness® Natural Food ...
... analyzing the genetics of cancers from different parts of the ... That process is already gaining traction at the ... where researchers are one year into a three-year project to ... gene expressed by 1,000 tumors. Over the past ...
... cellulose produced by bacteria could be used for artificial blood ... of blood clots than the synthetic materials currently used for ... the University of Gothenburg, Sweden. Produced by a bacterium ... enough to cope with blood pressure and works well with ...
... more serious infections than previously realised, with more than 3,000 ... Academy at the University of Gothenburg, Sweden. To date ... this often deadly infection is, but previously it has been ... in Sweden. A population-based review of cases in the county ...
... inherited form of disease , TUESDAY, Dec. 22 (HealthDay News) ... therapy may offer lifetime protection against the progression of the ... in mice. , The most common form of emphysema in ... in the alpha-1 anti-trypsin gene, the authors of the study ...
... , , ... ) today announced that its lending arm, IBM Global Financing, has ... (EHR) providers, highlighting the growing need for private financing for health ... adopt health IT solutions. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090416/IBMLOGO ) , ...
Cached Medicine News:Health News:Pets Resolve to 'Get Off On the Right Paw' in 2010 With a Healthy, Natural Diet and Exercise 2Health News:Pets Resolve to 'Get Off On the Right Paw' in 2010 With a Healthy, Natural Diet and Exercise 3Health News:Pets Resolve to 'Get Off On the Right Paw' in 2010 With a Healthy, Natural Diet and Exercise 4Health News:Chicago Cancer Genome Project studies genetics of 1,000 tumors 2Health News:Chicago Cancer Genome Project studies genetics of 1,000 tumors 3Health News:Chicago Cancer Genome Project studies genetics of 1,000 tumors 4Health News:Gene Therapy Holds Promise for Emphysema 2Health News:IBM Financing Agreements With Electronic Healthcare Record Providers Shatter Barriers To Health IT Adoption 2Health News:IBM Financing Agreements With Electronic Healthcare Record Providers Shatter Barriers To Health IT Adoption 3Health News:IBM Financing Agreements With Electronic Healthcare Record Providers Shatter Barriers To Health IT Adoption 4Health News:IBM Financing Agreements With Electronic Healthcare Record Providers Shatter Barriers To Health IT Adoption 5
PremierEdge Stab Knives - 15....
More Info Lacrimal Intubation Set. Size: Probes 23g x 7"....
... versatile and uncomplicated use of the Leica ... obtained make it the instrument of choice ... cryostat applications. The open top stainless steel ... accessible and offers ample space for convenient ...
The HM 550 series is a uniquely progressive concept for use with frozen specimens of all types. User applications define module selection and make even serial sectioning enjoyable....
Medicine Products: